Search Ontology:
ChEBI
canagliflozin
- Term ID
- CHEBI:73274
- Synonyms
-
- (1S)-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol
- 1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene
- Definition
- A C-glycosyl compound that is used (in its hemihydrate form) for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2.
- References
-
- CAS:842133-18-0
- Drug_Central:4758
- PMID:20690635
- PMID:21457428
- PMID:22226086
- PMID:22355316
- PMID:22385274
- PMID:22492586
- PMID:22548646
- PMID:22621689
- PMID:22632452
- PMID:23087012
- PMID:23279307
- PMID:23370138
- PMID:23412078
- PMID:23464594
- PMID:23563279
- PMID:23564919
- PMID:23585665
- PMID:23590413
- Patent:US2008146515
- Patent:US2010099883
- Patent:US2012289694
- Patent:WO2009035969
- Patent:WO2011142478
- Reaxys:18362681
- Wikipedia:Canagliflozin
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse has_part
-
Phenotype
Phenotype resulting from canagliflozin
Phenotype where environments contain canagliflozin
Phenotype modified by environments containing canagliflozin
Human Disease Model